Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,817 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the health-related quality of life using the 36-item short form health survey in patients with chronic hepatitis C receiving pegylated interferon/ribavirin/telaprevir triple treatment.
Suzuki M, Ishikawa T, Sakuma A, Abe S, Abe H, Koyama F, Nakano T, Ueki A, Noguchi H, Hasegawa E, Yamagata S, Kobayashi M, Ohashi K, Hirosawa H, Fukazawa T, Maruyama Y, Yoshida T. Suzuki M, et al. Among authors: ishikawa t. Exp Ther Med. 2016 Nov;12(5):3353-3358. doi: 10.3892/etm.2016.3785. Epub 2016 Oct 5. Exp Ther Med. 2016. PMID: 27882162 Free PMC article.
Health-related quality of life on the clinical course of patients with chronic hepatitis C receiving daclatasvir/asunaprevir therapy: A prospective observational study comparing younger (<70) and elderly (≥70) patients.
Ohashi K, Ishikawa T, Suzuki M, Abe H, Koyama F, Nakano T, Ueki A, Noguchi H, Hasegawa E, Hirosawa S, Kobayashi M, Hirosawa H, Sato K, Fukazawa T, Maruyama Y, Yoshida T. Ohashi K, et al. Among authors: ishikawa t. Exp Ther Med. 2018 Jan;15(1):970-976. doi: 10.3892/etm.2017.5488. Epub 2017 Nov 10. Exp Ther Med. 2018. PMID: 29399105 Free PMC article.
Relationship between pre-sarcopenia and quality of life in patients with chronic liver disease: a cross-sectional study.
Ohashi K, Ishikawa T, Imai M, Suzuki M, Hoshii A, Abe H, Koyama F, Nakano T, Ueki A, Noguchi H, Hasegawa E, Hirosawa S, Kobayashi M, Hirosawa H, Sato K, Munakata M, Yoshida T. Ohashi K, et al. Among authors: ishikawa t. Eur J Gastroenterol Hepatol. 2019 Nov;31(11):1408-1413. doi: 10.1097/MEG.0000000000001415. Eur J Gastroenterol Hepatol. 2019. PMID: 30964810
Effect of levocarnitine administration in patients with chronic liver disease.
Ohashi K, Ishikawa T, Hoshii A, Hokari T, Suzuki M, Noguchi H, Hirosawa H, Koyama F, Kobayashi M, Hirosawa S, Sugiyama K, Mitobe Y, Yoshida T. Ohashi K, et al. Among authors: ishikawa t. Exp Ther Med. 2020 Nov;20(5):94. doi: 10.3892/etm.2020.9222. Epub 2020 Sep 16. Exp Ther Med. 2020. PMID: 32973943 Free PMC article.
7,817 results